Clinicopathologic review of polyps biopsied at colonoscopy in Lagos, Nigeria

Clinicopathologic review of polyps biopsied at colonoscopy in Lagos, Nigeria

Aderemi Oluyemi^1,&, Nicholas Awolola², Olufemi Oyedeji²

 

¹ReMay Consultancy & Medical Services, Ikeja, Lagos, Nigeria, ²College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria

 

 

^&Corresponding author
Aderemi Oluyemi, ReMay Consultancy & Medical Services, Ikeja, Lagos, Nigeria

 

 

 

 

The burden of colorectal cancer (CRC) is huge in terms of morbidity and mortality throughout the world. They account for over 9% of all cancer incidence, are the third most common cancers worldwide and the fourth most common cause of cancer-related deaths [1,2]. A majority of CRC are thought to arise through a multi-step pathway which includes initial hyper-proliferation of normal epithelial cells, formation of adenomas and finally the transition to invasive carcinomas [3,4]. Detection of these polyps at colonoscopy and polypectomy has been shown to significantly reduce the incidence of CRC- by interrupting this adenoma-carcinoma sequence [5]. This is what gives particular relevance to the detection of polyps at colonoscopy. There has been little by the way of locally-based publications that have specifically focused on this important entity. However, a welcome development has been the recent rise in data concerning the prevalence of polyps in this region of the world- both as directly designed studies and as part of various colonoscopy audits [6-12]. This study was aimed at determining the prevalence of polyps among patients who underwent a colonoscopy at a private center in Lagos, Nigeria and to discuss their clinical features and the pathological findings.

 

 

Study design: this is a retrospective, hospital-based review.

 

Study methods: this retrospective analysis of prospectively collected data was performed using clinical information from the endoscopy logs and pathology database system of a private endoscopy suite in Lagos, Nigeria. All consecutive patients who had polyps diagnosed at colonoscopy over a 12 month period (August 2014 –July 2015) were included.

 

During the procedure, the colonic polyps were characterized by the following: location----the anatomical site of the polyp was documented; number---- whether the polyps were single or multiple was noted; appearance--- the masses were classified as either sessile or pedunculated.

 

Data presentation and definition of terms: the data is presented as simple proportions and the terms used are defined here as: Polyp Detection Rate- this is the number of colonoscopies in which polyps were detected taken as a proportion of the total number of such procedures that were carried out; Polyps per Colonoscopy Rate- this is the total number of polyps detected at colonoscopy taken as a proportion of the total number of such procedures that were carried out; Adenoma Detection Rate- this is the number of polyps that were histologically diagnosed as adenomatous taken as a proportion of the total number of colonoscopies.

 

 

One hundred and twenty five colonoscopies were performed over the 12 months covered by the study. There were 100 males; giving a male to female ratio of 2.5:1. Their ages ranged from 37 to 77 years (mean= 57.3 years) with majority of the patients within the 41-60 years age range (Figure 1). There was no statistically significant difference in the ages of both sexes. Fourteen individuals (11.2%) had a total of 18 polyps- 4 clients (28.6% of the people with polyps) had 2 polyps each. The major reason for colonoscopy referral was hematochezia as seen in 10 of the patients, the others were change in bowel habit in 3 patients while one was referred on account of perianal pain (Table 1). The polyps were distributed as follows in the colon; 8 in the sigmoid, 6 in the rectum, 1 each in the descending and transverse colon, and 2 in the ascending colon (Table 2). Hence, there was left sided (15 of 18= 83.3%) preponderance. Additional findings at colonoscopy included hemorrhoids 5(25.7%) patients in and diverticulosis in 2(14%). Two of the 18 polyps (11.1%) were semi-sessile and polypoidal while the rest were sessile (77.8%). Figure 2 illustrates the pattern of histological diagnoses that were made. Eight of the 18 polyps (44.4%) were tubular (adenomatous) with low grade dysplasia in all of them. Chronic colitis and inflammatory polyp were the reports in 5(27.8%) and 4(22.2%) patients respectively while 1(5.6%) each was reported as malignant and the rare inflammatory fibroid polyp. Thus the adenoma detection rate (ADR) was 6.4%. All the adenomatous lesions were located in the rectosigmoid.

 

 

There are no published population-based data on the prevalence of polyps in our setting, the range of quoted figures vary from very rare (e.g. 1 % from Okitipupa in South-West, Nigeria) to much more prevalent (e.g. 16.2% from Ile-Ife in South-West, Nigeria) but all are from hospital-based studies. The findings from some previous studies from our region are summarized in Table 3. A PDR of 11.2% is reported from this study. This figure is much higher than some earlier studies and lower than some recent ones [6-12]. The contrasting figures of PDR is likely due, at least in some part, to the variations in location and therefore predominant ethnic groups and the wide range in population sample sizes. All of the patients with polyps were symptomatic at the time of colonoscopy. This is in keeping with findings from local and international studies [6, 13]. A recent large, prospective, multicentre study concluded that the rates of detected polyps and advanced adenomas were much higher in symptomatic individuals [13]. Another important result of this study was that there was no significant difference in the CRC rates in asymptomatic patient’s vrs symptomatic ones. Hence, the researchers concluded that these results reinforce the importance of screening the symptom-free population to prevent CRC. Histologically, colorectal polyps are classified mainly as adenoma (neoplastic) or hyperplastic (non-neoplastic) [14]. Alatise and his team are the only ones to have previously documented ADR at colonoscopy in Nigerians from their study of polyps in Ile-Ife [6]. Their figure of 6.8% from 415 colonoscopies is similar to that presented in this study-6.4%, but much higher than the 2.9% quoted from Ghana by Dakubo et al [12]. This data is quite low when compared with larger surveys of Americans and Asians [15, 16]. Perhaps this data reflects the difference in prevalence rates of CRC across the continents- as the adenoma-carcinoma sequence is still thought to be a major etiopathogenetic mechanism for the development of CRC. The significance of these low ADR figures from our locality in terms of its long term correlation with the development of CRC is still under debate. The enquirers ask why such low ADR figures should explain the perceived increase in the number of CRC cases [6]. The adenoma-carcinoma sequence as the explanation for CRC’s etiopathogenesis in this population has been questioned and alternative route or routes to the cancer’s development opined [17-19]. The rectosigmoid was the site in 77% of the polyps, and all the adenomatous lesions were also in this part of the colon. This result parallels the observed patterns of anatomic distribution of CRC from various loco-regional reports [12, 20-22].The findings would therefore suggest that the use of rectosigmoidoscopy as an endoscopy tool for CRC screening in our locality is most welcome. Adenomatous polyps are still widely regarded as premalignant and rectosigmoidoscopy in this series would have picked 100% of them. The procedure has consistently been shown in prospective studies to be most useful in the fight against morbidity and mortality of CRC. A range of studies from across the globe have shown improved outcomes in patients who had as little as a single rectosigmoidoscopy done before the age of 50 and this benefit is said to increase with another such screen years after [23-29]. Bearing in mind that a recent mathematical modelling study showed that in the sub-Saharan African region, screening for CRC by colonoscopy at age 50 years in combination with treatment can be considered cost-effective and that the present rates of CRC screening of any kind in our environment are abysmal [30,31], rectosigmoidoscopy would appear to be a most screening tool. Particularly as it has the added advantage that it is cheaper, faster, easier to perform, training requirements are less and the rigors of bowel preparation demands are much reduced. So consistent are the results from other environments quoted earlier that only one of the referenced studies showed no benefit for rectosigmoidoscopy after long term follow up [27]. However, further analysis of the negative study did show that mortality from CRC was lower in the sub-population of hospital attenders- a reduction of 59% for any location of CRC and 76% for rectosigmoidal cancer [27].

 

 

The study supports the present wisdom that polyps are clearly less prevalent in our environment when compared to the Western world. The preponderance of males, advancing age and left sided lesions is also in keeping with previous results from our environment. The institution of cost-effective population based CRC screening programmes in our locality is espoused along with a suggestion of the deployment of endoscopy as a useful tool for such programmes.

 

 

The authors declare no competing interest.

 

 

Aderemi Oluyemi: conceived of this work, performed literature search, collected and analyzed data and reviewed the manuscript; Nicholas Awolola: performed literature search, collected and analyzed data and prepared the manuscript; Olufemi Oyedeji: collected and analyzed data and reviewed the manuscript critically for important intellectual content. All authors have read and agreed to the final version of this manuscript and have equally contributed to its content and to the management of the case.

 

 

We wish to thank the management of Clinix Health Limited for granting us access to their endoscopy log and histology database.

 

 

Table 1: showing the reasons for colonoscopy referral

Table 2: showing colonic distribution of polyps

Table 3: showing findings from similar loco-regional studies

Figure 1: pie chart showing age distribution of patients

Figure 2: bar chart showing the histological diagnosis of polyps, (LGD= low grade dysplasia)

 

 

1. World Cancer Research Fund (WCRF) and American Institute for Cancer Research Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research; 2007. Google Scholar


2. Boyle P, Langman JS. ABC of colorectal cancer: Epidemiology. BMJ. 2000; 321(7264): 805–808. PubMed | Google Scholar


3. Lipkin M, Higgins P. Biological markers of cell proliferation and differentiation in human gastrointestinal diseases. Adv Cancer Res. 1988; 50: 1-24. PubMed | Google Scholar


4. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996 Oct 18; 87(2): 159-70. PubMed | Google Scholar


5. Winawer SJ, Zauber AG, O’Brien MJ, Ho MN, Gottlieb L, Sternberg SS et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The national polyp study workgroup. N Engl J Med. 1993 Apr 1; 328(13): 901-6. PubMed | Google Scholar


6. Alatise OI, Arigbabu AO, Agbakwuru AE, Lawal OO, Sowande OA, Odujoko OO et al. Polyp prevalence at colonoscopy among Nigerians: A prospective observational study. Nig J Clin Pract. 2014; 17(6): 756-762. PubMed | Google Scholar


7. Ajayi AO, Ajayi EA, Solomon OA, Udo E. Lower gastrointestinal bleeding: spectrum of colonoscopy findings from Ado-Ekiti, Nigeria. Int J Med Med Sci. 2014; 6(5): 128-133. PubMed | Google Scholar


8. Onyekwere CA, Odiagah JN, Ogunleye OO, Chibututu C, Lesi OA. Colonoscopy practice in Lagos, Nigeria: a report of an audit. Diagn Ther Endosc. 2013; 2013: 798651. PubMed | Google Scholar


9. Ismaila BO, Misauno MA. Gastrointestinal endoscopy in Nigeria--a prospective two year audit. Pan Afr Med J. 2013; 14: 22. PubMed | Google Scholar


10. Olokoba AB, Obateru OA, Bojuwoye MO, Olatoke SA, Bolarinwa OA, Olokoba LB. Indications and findings at colonoscopy in Ilorin, Nigeria. Niger Med J. 2013; 54(2): 111-114. PubMed | Google Scholar


11. Obonna GC, Arowolo AO, Agbakwuru A. Experience with Colonoscopy in the Riverine Southwestern Nigeria. J West Afr Coll Surg. 2012; 2(2): 80-90. PubMed | Google Scholar


12. Dakubo J, Kumoji R, Naaeder S, Clegg-Lamptey J. Endoscopic evaluation of the colorectum in patients presenting with haematochezia at Korle-bu teaching hospital Accra. Ghana Med J. 2008; 42: 33-7. PubMed | Google Scholar


13. Blumenstein I, Tacke W, Bock H, Filmann N, Lieber E, Zeuzem S et al. Prevalence of colorectal cancer and its precursor lesions in symptomatic and asymptomatic patients undergoing total colonoscopy: results of a large prospective, multicenter, controlled endoscopy study. Eur J Gastroenterol Hepatol. 2013 May; 25(5): 556-61. PubMed | Google Scholar


14. Colucci PM, Yale SH, Rall CJ. Colorectal polyps. Clin Med Res. 2003 Jul; 1(3): 261-2. PubMed | Google Scholar


15. Boroff ES, Gurudu SR, Hentz JG, Leighton JA, Ramirez FC. Polyp and adenoma detection rates in the proximal and distal colon. Am J Gastroenterol. 2013 Jun; 108(6): 993-9. PubMed | Google Scholar


16. Chung SJ, Kim YS, Yang SY, Song JH, Park MJ, Kim JS et al. Prevalence and risk of colorectal adenoma in asymptomatic Koreans aged 40-49 years undergoing screening colonoscopy. J Gastroenterol Hepatol. 2010 Mar; 25(3): 519-25. PubMed | Google Scholar


17. Burkitt DP. Epidemiology of cancer of the colon and rectum. Cancer. 1971; 28(1): 3-13. PubMed | Google Scholar


18. Adekunle OO, Lawani JA. Clinical aspects and management of carcinoma of the rectum in Nigerians. East African Medical Journal. 1982; 59(3): 206-213. PubMed | Google Scholar


19. Alese OB, Irabor DO. Adenomatous polyposis coli in an elderly female Nigerian. Ghana Med J. 2009 Sep; 43(3): 139-41. PubMed | Google Scholar


20. Ibrahim KO, Anjorin AS, Afolayan AE, Badmos KB. Morphology of colorectal carcinoma among Nigerians: a 30-year review. Niger J Clin Pract. 2011 Oct-Dec; 14(4): 432-5. PubMed | Google Scholar


21. Anyanwu SN. Colorectal adenocarcinoma in Eastern Nigeria: sub-site distribution and surgical treatment patterns. J Clin Oncol. 2010; 28(Suppl abstract): e14111. PubMed | Google Scholar


22. Abdulkareem FB, Abudu EK, Awolola NA, Elesha SO, Rotimi O, Akinde OR et al. Colorectal carcinoma in Lagos and Sagamu, Southwest Nigeria: a histopathological review. World J Gastroenterol. 2008; 14(42): 6531-6535. PubMed | Google Scholar


23. Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Doria-Rose VP, Laiyemo AO et al. Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination. J Natl Cancer Inst. 2012 Feb 22; 104(4): 280-9. PubMed | Google Scholar


24. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012 Jun 21; 366(25): 2345-57. PubMed | Google Scholar


25. Segnan N, Armaroli P, Bonelli L, Risio M, Sciallero S, Zappa M et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian randomized controlled trial – SCORE. J Natl Cancer Inst. 2011 Sep 7; 103(17): 1310-22. PubMed | Google Scholar


26. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: A multicentre randomised controlled trial. Lancet. 2010; 375(9726): 1624-33. PubMed | Google Scholar


27. Hoff G, Grotmol T, Skovlund E, Bretthauer M. Norwegian colorectal Cancer Prevention Study Group. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ. 2009; 338: b1846. PubMed | Google Scholar


28. Sung JJ, Lau JY, Young GP, Sano Y, Chiu HM, Byeon JS et al for the Asia Pacific Working Group on Colorectal Cancer. Asia Pacific consensus recommendations for colorectal cancer screening. Gut. 2008; 57(8): 1166-76. PubMed | Google Scholar


29. Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Church T, Yurgalevitch S et al; PLCO Project Team. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst. 2005; 97(13):989-97.. PubMed | Google Scholar


30. Ginsberg GM, Lauer JA, Zelle S, Baeten S, Baltussen R. Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study. BMJ. 2012; 344: e614. PubMed | Google Scholar


31. Onyekwere CA, Ogbera AO, AbdulKareem FB, Ashindoitiang J. Colorectal carcinoma screening in Lagos, Nigeria, are we doing it right?. Gastroenterology Research. 2009; 2: 38-42. PubMed | Google Scholar